{"id":"W2566075579","doi":"10.1182/blood.v104.11.5230.5230","title":"Rituximab + ESHAP as Salvage Chemotherapy for Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma: A Phase II Trial.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Etoposide; Salvage therapy; Oncology; Aggressive lymphoma; Autologous stem-cell transplantation; Chemotherapy; Gastroenterology; Lymphoma; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001521363,0.001209114,0.00158085,0.0004322308,0.0002937949,0.0008882996,0.0009522076,0.001293952,0.003957519],"category_scores_gemma":[0.0006352164,0.0004885955,0.001098637,0.0004580866,0.00077802,0.0008793556,0.0003552652,0.002296875,0.0008792564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006111976,"about_ca_system_score_gemma":0.0009169268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000665668,"about_ca_topic_score_gemma":0.001559551,"domain_scores_codex":[0.9996353,0.0002183891,0.00001810412,0.00004349061,0.00002516952,0.00005955152],"domain_scores_gemma":[0.9994859,0.00008710854,0.00009318612,0.0000431721,0.00003004614,0.0002606893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8619741,0.0396182,0.002537419,0.001547999,0.00218958,0.0002541652,0.0001594772,0.00153561,0.01000466,0.0002972127,0.002914687,0.07696684],"study_design_scores_gemma":[0.8364224,0.1569908,0.003071471,0.00006892431,0.0005228228,0.0001299607,0.00003643386,0.0006059049,0.00061694,0.0001428856,0.001378222,0.00001330038],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845223,0.007672737,0.0005178347,0.000644256,0.0003221269,0.003239994,0.0006608083,0.0001134788,0.002306331],"genre_scores_gemma":[0.9832965,0.004984489,0.001348228,0.00126936,0.0004584019,0.003856218,0.001115818,0.00001709363,0.003653767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003957519,"threshold_uncertainty_score":0.0132392,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01465447122387212,"score_gpt":0.3036123395581574,"score_spread":0.2889578683342853,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}